Barilla-LaBarca Maria-Louise, Atkinson John P
Department of Medicine, State University of New York (SUNY) at StonyBrook, USA.
Curr Opin Rheumatol. 2003 Jan;15(1):55-60. doi: 10.1097/00002281-200301000-00010.
Deficiency of an early component of the classical complement pathway, C1q, C1r/C1s, C4, or C2, regularly produces autoimmunity in man, especially systemic lupus erythematosus. It has long been suggested that disruption of this pathway would lead to the inappropriate handling of immune complexes. An intriguing hypothesis that builds on this idea relates to a defect in clearance of one's own cellular debris, namely apoptotic cells. An attractive feature of this emerging concept is that blebs on apoptotic cells are decorated with antigens to which much of the autoantibody specificity is directed in systemic lupus erythematosus. A second hypothesis, generated primarily from complement deficiencies, relates to an impairment in the humoral immune response or in the regulation of autoreactive B cells. This review begins by summarizing the recognized autoimmune manifestations of complement deficiency and then describes new data derived from targeted gene deletions of complement proteins.
经典补体途径早期成分(C1q、C1r/C1s、C4或C2)的缺乏通常会在人类中引发自身免疫,尤其是系统性红斑狼疮。长期以来,人们一直认为该途径的破坏会导致免疫复合物处理不当。基于这一观点的一个有趣假说是关于自身细胞碎片(即凋亡细胞)清除缺陷。这一新兴概念的一个吸引人之处在于,凋亡细胞上的泡状结构带有自身抗体特异性在系统性红斑狼疮中所指向的许多抗原。第二个主要源于补体缺陷的假说是关于体液免疫反应受损或自身反应性B细胞调节受损。本综述首先总结补体缺乏公认的自身免疫表现,然后描述从补体蛋白靶向基因缺失获得的新数据。